Free

Event Information

Share this event

Date and Time

Location

Location

The California Endowment Oakland Regional Office

2000 Franklin Street

Oakland, CA 94612

View Map

Event description

Description

The California Technology Assessment Forum (CTAF) a core program of the Institute for Clinical and Economic Review (ICER), will hold a public meeting on June 11, 2019 to consider the comparative clinical effectiveness and value of oral immunotherapy and Viaskin® Peanut (DBV Technologies) for the treatment of peanut allergy.

Peanut is a common childhood allergen in the United States. According to recent estimates approximately 1.4-4.5% of children suffer from peanut allergy. Food allergy reactions can range from mild cutaneous symptoms, to gastrointestinal symptoms such as abdominal pain, nausea, vomiting, and diarrhea, on to anaphylaxis. Peanut allergy is the leading cause of death from anaphylaxis due to food, particularly in teenagers. The allergy usually begins early in life and only a minority of patients outgrow their food allergy.

A list of key dates for stakeholder engagement opportunities and other important information associated with the review of oral immunotherapy and Viaskin® Peanut for peanut allergy can be found on ICER's website at https://icer-review.org/topic/peanut-allergy/.

Share with friends

Date and Time

Location

The California Endowment Oakland Regional Office

2000 Franklin Street

Oakland, CA 94612

View Map

Save This Event

Event Saved